Human Growth Hormone – Insights into its Aggregation Behavior using Denaturation Pathway Characterization
1
Research Center Pharmaceutical Engineering GmbH, Graz, Austria
2
Institute of Biotechnology and Biochemical Engineering, University of Technology Graz, Graz, Austria
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 594; https://doi.org/10.3797/scipharm.cespt.8.PDD05
Submission received: 12 July 2010
/
Accepted: 12 July 2010
/
Published: 12 July 2010
Abstract
Protein denaturation processes involving aggregation are among the prime factors impeding the development of stable protein drug formulations. [...]
Share and Cite
MDPI and ACS Style
WIESBAUER, J.; LEITGEB, S.; NIDETZKY, B. Human Growth Hormone – Insights into its Aggregation Behavior using Denaturation Pathway Characterization. Sci. Pharm. 2010, 78, 594. https://doi.org/10.3797/scipharm.cespt.8.PDD05
AMA Style
WIESBAUER J, LEITGEB S, NIDETZKY B. Human Growth Hormone – Insights into its Aggregation Behavior using Denaturation Pathway Characterization. Scientia Pharmaceutica. 2010; 78(3):594. https://doi.org/10.3797/scipharm.cespt.8.PDD05
Chicago/Turabian StyleWIESBAUER, J., S. LEITGEB, and B. NIDETZKY. 2010. "Human Growth Hormone – Insights into its Aggregation Behavior using Denaturation Pathway Characterization" Scientia Pharmaceutica 78, no. 3: 594. https://doi.org/10.3797/scipharm.cespt.8.PDD05
